Recombinant thrombomodulin inhibits arterial smooth muscle cell proliferation induced by thrombin

Journal of Vascular Surgery

Volumn 32, Issue 4, 2000, Pages 804-813

  Li, Jian Ming ^a   Garnette, Charles S C ^a   Cahn, Mitchell ^a   Claytor, R Brannon ^a   Rohrer, Michael J ^a   Dobson Jr , James G ^b   Gerlitz, Bruce ^c   Cutler, Bruce S ^a  

^a Division of Vascular Surgery   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIRUDIN; RECOMBINANT THROMBOMODULIN; THROMBIN; THROMBIN RECEPTOR ACTIVATING PEPTIDE;

ANIMAL CELL; ARTICLE; CAROTID ARTERY; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; NONHUMAN; PRIORITY JOURNAL; SWINE; THROMBOSIS; THROMBOSIS PREVENTION; VASCULAR SMOOTH MUSCLE;

EID: 0033789547     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1067/mva.2000.107992     Document Type: Article

References (46)

1. A comparison of directional atherectomy with balloon angioplasty for lesions of the left anterior descending coronary artery
2. A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease: The CAVEAT Study Group
3. Vascular smooth muscle cell proliferation: Basic investigations and new therapeutic approaches
4. Thrombin: A versatile protease in restenosis
5. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor
6. The effect of thrombin on bovine aortic endothelial and smooth muscle cells
7. Thrombin-elicited contractile responses of aortic smooth muscle (42211)
8. Antithrombotic strategies targeting thrombin activities, thrombin receptors and thrombin generation
9. Thrombin mediation of arterial smooth muscle cell (SMC) proliferation after mechanical vascular injury in non-human primates
10. Failure of heparin to inhibit intimal hyperplasia in injured baboon arteries
11. Neointimal proliferation: The role of basic FGF on vascular smooth muscle cell proliferation
12. Antisense basic fibroblast growth factor gene tranfer reduces early intimal thickening in a rabbit femoral artery balloon injury model
13. Current concepts in restenosis following balloon angioplasty
14. Overexpression of tissue inhibitor of matrix metalloproteinase-1 inhibits vascular smooth muscle cell functions in vitro and in vivo
15. Vascular gene therapy in the 21st century
16. Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C
17. Thrombomodulin as a model of molecular mechanisms that modulate protease specificity and function at the vessel surface
18. Isolation of a membrane-bound cofactor for throm-catalyzed activation of protein C
19. Structure and expression of human thrombomodulin, a thrombin receptor on endothelium acting as a cofactor for protein C activation
20. Human thrombomodulin: Complete cDNA sequence and chromosome localization of the gene
21. Characterization of a thrombomodulin cDNA reveals structurral similarity to the low density lipoprotein receptor
22. The structure and function of mouse thrombomodulin
23. Stable expression of a secretable deletion mutant of recombinant human thrombomodulin in mammalian cells
24. Recombinant human thrombomodulin: Regulation of cofactor activity and antocoagulant function by a glycosaminoglycan side chain
25. 474
26. Intravenous recombinant soluble human thrombomodulin prevents venous thrombosis in a rat model
27. Recombinant soluble human thrombomodulin: A randomized, blinded assessment of prevention of venous thrombosis and effect on hemostatic parameters in a rat model
28. Antithrombotic effect of recombinant human thrombomodulin on thrombin-induced thromboembolism in mice
29. Recombinant human thrombomodulin attenuates human endothelial cell activation by human thrombin
30. Surface thrombomodulin modulates thrombin receptor responses on vascular smooth muscle cells
31. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
32. Substancce P enhances the secretion of TNF alpha from neuroglial cells stimulated with LPS
33. Cell-cycle analysis using a monoclonal antibody to BrdUrd
34. Restenosis after coronary angioplasty: Its pathogenesis and prevention
35. Evaluation of recombinant hirudin (CGP 39 393/(TM) REVASC) in the prevention of restenosis after percutaneous transluminal coronary angioplasty: Rationale and design of the HELVETICA trial, a multicentre randomized double blind heparin controlled study
36. A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty
37. Treatment with Bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina
38. Intimal hyperplasia following vascular injury is not inhibited by an antisense thrombin receptor oligodeoxynucleotide
39. Studies on the pharmacokinetics of hirudin
40. In vivo behavior of detergent-solubilized purified rabbit thrombomodulin on intravenous injection into rabbits
41. Molecular mechanisms of thrombin signaling
42. Expression of thrombomodulin in atherosclerotic lesions and mitogenic activity of recombinant thrombomodulin in vascular smooth muscle cells
43. Effect of renal and genetic hypertension and endotoxin injections on cultivated smooth muscle cells derived from different regions of the aorta
44. The epidermal growth factor-like domain of recombinant human thrombomodulin exhibits mitogenic activity for Swiss 3T3 cells
45. The anion-binding exosite is citical for the high affinity binding of thrombin to the human thrombin receptor
46. Thrombin mutants with altered enzymatic activity have an impaired mitogenic effect on mouse fibroblasts and are inefficient modulators of stellation of rat cortical astrocytes